Autopsy report · NCT05197699

Severe Acute Respiratory Syndrome Coronavirus Type 2 (SARS-CoV-2)-Related Multiple Sclerosis (MS) Vaccination Study

Cause of deathFunding or business Automatic label, confidence 0.9, unverified. How labels are made.

“Sponsor's decision”

The sponsor’s own words in the registry.

Life of this trial

Registered 7 months after it had already started.
Ran for about 2 years 3 months before it stopped.
160 participants enrolled.
No results are posted on the registry.

Vital statistics

Status: Terminated
Sponsor: Biogen
Sponsor type: Industry
Conditions: Multiple Sclerosis (MS)
Participants: 160
Sites: 12
Countries: Germany

Trials that died the same way

Everolimus With and Without Temozolomide in Adult Low Grade Glioma
“Sponsor decision” (98% match in meaning)

Look deeper

The official registry record (the source of truth)
Record history: every change the sponsor made
Open it in the database

Everything here comes from the current ClinicalTrials.gov record. The timeline uses the record’s dates; dates marked planned are the sponsor’s plans. The cause of death is an automatic, unverified label. This is research information, not medical advice.